Closed
3.84 -7.25
24h
Min
3.76
Max
4.37
Income | 98K -50M |
---|---|
Sales | 6.2M 13M |
EPS | -0.58 |
Profit margin | -382.531 |
Employees | 274 |
EBITDA | 789K -54M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +417.63% upside |
Next Earnings | 8 maj 2025 |
---|
Market Cap | -129M 467M |
---|---|
Previous open | 11.09 |
Previous close | 3.84 |
By Trading Central
Confidence
Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 21.43 USD 417.63%
High 32 USD
Low 15 USD
Based on 8 Wall Street analysts offering 12 month price targets forVerve Therapeutics Inc - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$